No connection

Features Terminal AI Assistant

Symbol search

/fundamentals

Enter to jump straight to the ticker page.

Search Results

Corporate Score 55 Neutral

Neurocrine to buy Soleno Therapeutics for $2.9 billion

Apr 06, 2026 11:12 UTC

NBIX, SLNO, ^GSPC

Short term

Neurocrine to buy Soleno Therapeutics for $2.9 billion.

Share this article

Article Stats

Impact

55

Sentiment

Neutral

Type

Corporate

Horizon

Short

Risk Level

Medium

Affected Symbols

Intelligence Terminal Fundamental Analysis Ask AI About This Advanced Chart More News

Intelligence Terminal Fundamental Analysis Ask AI About This Advanced Chart More News

Intelligence Terminal Fundamental Analysis Ask AI About This Advanced Chart More News

Analyze This News with AI

AI will analyze the impact on affected symbols and provide trading insights

Unlock Premium

Get AI-powered insights, advanced filtering, real-time alerts, and unlimited analysis.

Unlimited AI market analysis
Advanced news filtering
Real-time price alerts
AI trading assistant

View Plans Sign Up Free

Related Articles

Score 75 Bearish

Bitcoin Slides With Risk Assets as Trump’s Iran Ultimatum Looms

Apr 07, 05:19

Stay Ahead of the Markets

Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.

Get Started Free View Plans